Authors:
GRISSO JA
KELSEY JL
OBRIEN LA
MILES CG
SIDNEY S
MAISLIN G
LAPANN K
MORITZ D
PETERS B
HIBBERD A
CLANCY M
COTLER J
DELONG W
ECKER M
FRIEDENBERG ZB
GOOD R
HUMMER C
MARKMAN W
MOOAR P
STEIN H
WOHL M
ZASLOW D
Citation: Ja. Grisso et al., RISK-FACTORS FOR HIP FRACTURE IN MEN, American journal of epidemiology, 145(9), 1997, pp. 786-793
Authors:
ALTENSCHMIDT U
KAHL R
MORITZ D
SCHNIERLE BS
GERSTMAYER B
WELS W
GRONER B
Citation: U. Altenschmidt et al., CYTOLYSIS OF TUMOR-CELLS EXPRESSING THE NEU ERBB-2, ERBB-3, AND ERBB-4 RECEPTORS BY GENETICALLY TARGETED NAIVE T-LYMPHOCYTES/, Clinical cancer research, 2(6), 1996, pp. 1001-1008
Citation: Bs. Schnierle et al., EXPRESSION OF CHIMERIC ENVELOPE PROTEINS IN HELPER-CELL LINES AND INTEGRATION INTO MOLONEY MURINE LEUKEMIA-VIRUS PARTICLES, Gene therapy, 3(4), 1996, pp. 334-342
Authors:
HEKELE A
DALL P
MORITZ D
WELS W
GRONER B
HERRLICH P
PONTA H
Citation: A. Hekele et al., GROWTH-RETARDATION OF TUMORS BY ADOPTIVE TRANSFER OF CYTOTOXIC T-LYMPHOCYTES REPROGRAMMED BY CD44V6-SPECIFIC SCFV-ZETA-CHIMERA, International journal of cancer, 68(2), 1996, pp. 232-238
Citation: D. Moritz et B. Groner, A SPACER REGION BETWEEN THE SINGLE-CHAIN ANTIBODY-CHAIN AND THE CD3 ZETA-CHAIN DOMAIN OF CHIMERIC T-CELL RECEPTOR COMPONENTS IS REQUIRED FOR EFFICIENT LIGAND-BINDING AND SIGNALING ACTIVITY, Gene therapy, 2(8), 1995, pp. 539-546
Authors:
GOUILLEUX F
MORITZ D
HUMAR M
MORIGGL R
BERCHTOLD S
GRONER B
Citation: F. Gouilleux et al., PROLACTIN AND INTERLEUKIN-2 RECEPTORS IN T-LYMPHOCYTES SIGNAL THROUGHA MGF-STAT5-LIKE TRANSCRIPTION FACTOR, Endocrinology, 136(12), 1995, pp. 5700-5708
Citation: D. Moritz et al., MORTALITY-RATES AND CAUSES OF DEATH AMONG ALZHEIMERS-DISEASE PATIENTSIN CALIFORNIA, Neurobiology of aging, 15, 1994, pp. 190000047-190000048
Citation: D. Moritz et al., CYTOTOXIC T-LYMPHOCYTES WITH A GRAFTED RECOGNITION SPECIFICITY FOR ERBB2-EXPRESSING TUMOR-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(10), 1994, pp. 4318-4322